#GoForGoldCycle2022

We are the Cancer Bioengineering Group, and September is a very special month for us as it is Childhood Cancer Awareness Month. Childhood cancer is the 2nd leading cause of death in children after accidents. Our group researches childhood cancer neuroblastoma, a cancer of immature nerve cells. Neuroblastoma is responsible for approximately 15% of all childhood cancer deaths. Despite intensive multimodal treatment, as many as 1 in 5 children with the aggressive disease do not respond, and up to 50% of children that do respond experience disease recurrence with many metastatic tumours resistant to many drugs and more aggressive tumour behaviour that all too frequently results in death.

This is what we want to change! We believe that every child deserves a future, and our team of postgraduate researchers led by Dr Olga Piskareva is dedicated to strengthening our knowledge of this disease and identifying new potential ways to tackle it, as well as taking part in fundraising activities so our group and others can continue with this research.  

On Wednesday, the 21st of September, RCSI 123 SSG will #GoGold in support of this cause. Please come by to see the RCSI building lit up and share your pictures on social media with the hashtag #ChildhoodCancerAwarenessMonth to raise awareness.

How are you, PI?

Yeah, our (my) blogging is sporadic. The pattern is well recognisable – more posts with success stories or accomplishments or about the key activities. It is easy to share :). Please excuse us (me) when we are off the radar, but we remember our supporters and readers. We are back on track to celebrate Childhood Cancer Awareness Month this September.

So, how did my summer go? Well, nothing to complain about. I had time to go back to the labs, pick up on the outstanding task, and take on the white coat. Indeed, it comes with some assurance as well as troubleshooting. Some days were better than others. Some experiments worked, and another was inconsistent or inconclusive.

A fancy photo, but the routine cell culture itself can be very boring.

Where did I pick it up? This research journey is one year old already. 🙂 This project is focused on validation our 3D neuroblastoma model to test novel therapeutics. We set an experiment that required different expertise and contribution from every team member. In an ideal world, it was supposed to finish in 6 months. But the reality doesn’t stop to shake you. Various components have been delayed sometimes due to unforeseen circumstances (e.g. a broken equipment or out of stock reagent) or due to the lack of manpower or miscommunication at a given time. Eventually, we put the work on hold in October 2021, when we completed ~60%. Another go to continue was taken in April 2022. No luck! Then plan B was activated, and I have been back in the labs. Despite these challenges, this time has not been lost. We developed new ideas to complement the original plan. Now, the crucial 20% has to be done and dusted within 2 weeks time before teaching starts. Wish us a luck!

After the challenge of leading the Foundation Year Medicine Cycle, I am 100% positive that I love research with all up and downs. This routine is fascinating, it is not static. One day differs from another. Research questions are flowing in non-stop…

September 2022 is Childhood Cancer Awareness Month

Today marks the start of Childhood Cancer Awareness Month, which we celebrate every year to support and learn more about kids with cancer, their loving families, the doctors and caregivers who look after them and treat them, the young survivors of cancer and those kids and teens who lost their battle, and the scientists who working hard to find a way to stop childhood cancer.

Childhood cancer is an umbrella term for many other types of this disease. Every 100th cancer patient is a child. Cancer is the 2nd most common cause of death among children after accidents. When it comes to a disease, we have to acknowledge that children are not little adults. They are constantly developing. So their diseases have different ways of progressing and responding to treatment. The causes of childhood cancer, including neuroblastoma, are not known. It would be right to expect more blind alleys and failed ideas in understanding these cancers. To address these challenges, more curiosity-driven and translationally focused research is needed.

The illustration was created by Luiza Erthal

The most common childhood cancers:

  • Leukaemia and lymphoma (blood cancers)
  • Brain and other central nervous system tumours
  • Muscle cancer (rhabdomyosarcoma)
  • Kidney cancer (Wilms tumour)
  • Neuroblastoma (tumour of the non-central nervous system)
  • Bone cancer (osteosarcoma)
  • Testicular and ovarian tumours (gonadal germ cell tumours)

Congratulations Dr Frawley!

June 9th 2022 – A Big Day for Tom and me. This is the end of the 4th year PhD marathon. A long journey through scattered showers and sunny spells, gale winds and stormy snow with sunshine developing elsewhere, turning chilly under clear skies on some days with temperatures below/above zero. The full spectrum of emotions and hard work spiced up with the COVID19 restrictions’ uncertainty. All these together have moulded into a new high skilled researcher – Dr Thomas Frawley.

My greatest thanks to Tom’s examiners Profs Elena Aikawa (Harvard Medical School, USA) and Marc Devocelle (RCSI, Ireland)!!

This work would not be possible without the generous support from the Irish Research Council and National Children’s Research Centre.

Not quite all back to in-person – the EFEM student Symposium 2022

Despite our last blog post celebrating the regained opportunity to meet with other researchers in person and all the benefits that come with it I just had the pleasure of presenting at the first European Federation for Experimental Morphology (EFEM) Student Symposium online.

While it would have been easy for me to attend in person, as the event was hosted and organised here at RCSI, not many others would have had it quite so easy. As the name suggests, researchers from all across Europe attended. Every EFEM associated anatomical society across Europe and RCSI, as the host institution, had the opportunity to select two members to present. I was honoured to be chosen to represent RCSI. Overall, 15 different countries were represented in the student talks which made for a diverse mix that was particularly nice for the bit of organized fun at the end of the first day which encouraged networking.

Especially, because having only begun my PhD this past year I felt the category Preliminary Results and Outlook aimed at Undergrads, Masters and early-stage PhD students perfectly suited the stage of my project. This was also a brilliant way to see what other students at my level were doing in the field of anatomical research all across Europe. Having this chance to see research in progress was refreshing and uplifting contrasted with the usually more rounded later stage presentations. Having studied anatomy in my undergraduate degree I was also delighted to simply engage with more conventional anatomical research than I currently do myself.

Ronja Struck, 1Yr PhD student at the EFEM Student Symposium 2022

A wonderful opportunity to gain insights into, for example, the implicit knowledge of academia was the career development part of the conference. Talks about academia, industry and publishing offered a chance to get an inside view of those career paths at different positions within them. Especially the typical day in a research journal’s editor provided a new perspective on what is important when writing papers and will have lasting benefits for me and my scientific writing.

But by far the reason why I’ll remember this conference for the longest time is that being awarded runner up in the category Preliminary Results and Outlook reassured me that I am on the right track and that there is purpose in what I do. Despite the online format of the conference, I had the honour of receiving my prize in person, because Prof. Fabio Quondamatteo, the organiser of the event is based at RCSI.

Overall, the two days were an important step in consolidating my faith in my work and the career path that I have chosen.

Written by Ronja Struck, the IRC-CFNCRF funded PhD student

Return of the in-person conference – IACR2022

In-person conferences are back at last! In March 2021 I attended the IACR conference for the first time, albeit virtually. While there were some great talks at IACR 2021, the virtual experience was lacking in the networking and socialising opportunities that go hand-in-hand with traditional conferences. So I was very excited to be Cork-bound for IACR 2022 in March of this year.

To my surprise, my abstract was selected for a Proffered talk, meaning I had 10 minutes in the limelight of the IACR podium to present my research on immune markers in neuroblastoma. Having gone two years without presenting to a crowd, it was an adrenaline-filled experience, and it was great being surrounded by my colleagues after the talk rather than being at home alone in front of my computer.

Catherine Murphy, PhD student at IACR2022

There were many very memorable research talks and posters at IACR, but some of the best memories came from the moments in between the scientific sessions. From the train down to Cork with my lab group, to buffet dinners, a quick journey into Cork city, going for a swim in the lovely hotel pool, and singing and dancing the night away at the gala dinner on the last day of the conference.

One of the highlights of the conference for me was the awards ceremony at the gala dinner, where to my delight I was awarded the Best Proffered PhD talk! What a fantastic way to end a great few days at IACR 2022.

Written by Catherine Murphy

IACR Meeting 2022: 2 years + a pandemic in between

It was February 2020, just before one of the biggest global pandemics struck, that I attended the IACR as a research assistant. It was my first official conference and it is safe to say ‘Imposter Syndrome’ was my main feeling going down to Galway on the train. Fast forward 2 years and my feelings travelling to IACR 2022 in Cork could not be more different. It is amazing what starting a PhD during a pandemic can do for your confidence and skills as a researcher – a sink or swim moment if there was ever one. My first IACR in Galway was one to remember surrounded by like-minded scientists, all brimming with new ideas and exciting discoveries. As such, I had high hopes for IACR 2022. And it did not disappoint.

Ellen King, PhD student at the IACR Meeting 2022

My PhD project focuses on the development of a vaccine to treat neuroblastoma so I was very excited to hear talks from some of the leading experts in vaccine research, both in industry and academia. I gained so much from hearing these experts discuss their research but also discussing other important topics like career progression and how to keep a work/life balance in research. It was refreshing to hear that as scientists we don’t have to (and shouldn’t) work ourselves to the bone 24/7 to be successful. As a young scientist planning to continue into academic research, this left a lasting impression on me. To top off what was already a hugely beneficial conference for me, my poster was shortlisted for a prize. I was shocked, delighted and excited all-in-one. Starting my PhD during a pandemic was not without challenges. Delays in deliveries, delays getting trained on equipment and multiple lockdowns led to what felt like (for me) quite a disjointed start. For my research to be shortlisted by experts was, to be honest, a relief. To know that my work stood out was extremely important to me and that all the hard work does pay off. When my name was called out at the Gala dinner as a Poster Prize Winner, all the doubts that I had (doubts that we all have as scientists) disappeared. I felt very proud and very grateful that my research was recognised at that level. There is no doubt that in-person conferences give a huge boost to young researchers, and I really look forward to presenting my work at the next IACR meeting.

Written by Ellen King

First Research Meeting For A Medical Student

At the beginning of my career, I worked for two years in a Ukrainian company organizing international industrial conferences. So I have insider knowledge of how the conference works, and that the determining factor for the success is the active communication between the participants. And at the RCSI research day and Cork IACR conference, this component was perfect. At both events, I presented my poster and had a chance to discuss the recent advances in neuroblastoma epigenetic drug research. During RCSI Research day, I was excited to learn about the accomplishments of other undergraduate studies and was thrilled to learn that my classmate is participating in research too. He had developed an online recourse to practice cardiac auscultation, which is extremely useful for my medical studies. But professionally, I enjoyed the cancer research posters and presentations at the IACR conference and was eager to meet the researchers working on medulloblastoma, a paediatric neural cell cancer, and the research team from UCD, the neighbours of our university who worked on breast cancer. It was the most valuable opportunity to take a glimpse into other research, become inspired by the most ingenious methods, and cultivate professional knowledge and personal connections – I am so lucky I have been at RCSI Research day and the IACR conference! I have greatly enjoyed my time, and I am looking forward to (hopefully) going to the next year’s conferences again.

Written by Nadiya Bayeva

RCSI Research Day 2022

Cancer Bioengineering Group thoroughly enjoyed getting back to in-person Research Day at RCSI after 2 years, we’re now very much looking forward to the IACR conference later this month! We will have 2 oral and 5 poster presentations at IACR 2022.

Dream Team in action

Ronja: My typical day

A typical day for me is difficult to describe because there are many facets to a PhD in the Cancer Bioengineering research group. Some days I spend in the lab sectioning, staining or looking at tumour samples under the microscope. Others I stay at home, read papers and try to figure out how they can help me to achieve my research goals. Some days I take part in the courses and workshops offered in the scope of a structural PhD. Then there are times when I sit here writing up for you guys what it is that I do those other days. The academic environment also provides lots of other opportunities to apply yourself and broaden your horizons or pursue what you enjoy. I, for example, have the chance to partake in weekly dissections for medical teaching which helps to keep my anatomical knowledge fresh and is an always welcome change of scenery (and smell) when I am stuck on other things. Furthermore, I get to see the other side of conferences and what is involved in their planning, because I am part of the local organising committee for the European Federation for Experimental Morphology Symposium 2022.

Figure 1 Working on neuroblastoma cancer the samples I am working with are quite unsurprisingly tumour cells. But these can be grown, for example, in mice (A) or on manmade scaffolds (D).  I am moving a staining rack that holds the microscopy slides through staining containers filled with different solutions (C) to stain the slides. After the slides are stained the excess stain is removed by washing in distilled water (B). The resulting images depend on the type of stain. Stains like Alcian Blue can only be viewed with brightfield microscopy (A). But Picrosirius red can also be viewed under polarised light or as seen here (D) with fluorescent microscopy.

Currently, not yet half a year into my PhD, a lot of my time is spent planning. That’s planning which methods to use, which products to order and which experiments, and analyses would result in the most coherent and rounded off story being told by the summation of my research. I also spend a lot of time optimising the methods I will use to assure reproducibility and avoid issues during the analysis later on. For example, the whole tumour sample stained with Alcian blue you can see in Figure 1A clearly shows discernible blue and red regions. However, I have spent about 2 months now trying to get to a point of producing this same outcome reliably rather than having samples show up entirely blue or very only faintly stained. Picrosirius red, the solution I used to stain the sample in Figure 1D stains collagen. But there are many different stains for collagen. After researching most if not all of them I chose this one because it can be viewed with different types of microscopies providing slightly different information. Another step of planning includes how many pictures of which magnification will be required, one image of a whole section for orientation such as in Figure 1A and then more zoomed-in images to investigate the structure of collagen such as in Figure 1D.

Between course work and planning and optimising different aspects of my project, my PhD provides me with plenty of opportunities to focus on something else whenever I get stuck to later return with a fresh set of eyes.

Written by Ronja Struck, a 1st Yr PhD student funded by the IRC-CFNCRF